Join the Chronic Kidney Disease group to help and get support from people like you.
Chronic Kidney Disease News (Page 5)
Related terms: CKD, Chronic Renal Disease, CRD
Kidney Trouble Could Mean Tooth Loss for Older Women
WEDNESDAY, June 12, 2024 – Older women with chronic kidney disease might wind up losing so many teeth they aren’t able to chew and talk effectively, a new study warns. Postmenopausal women with k...
Kidney Trouble Could Mean Tooth Loss for Older Women
WEDNESDAY, June 12, 2024 – Older women with chronic kidney disease might wind up losing so many teeth they aren’t able to chew and talk effectively, a new study warns. Postmenopausal women with k...
Kidney Trouble Could Mean Tooth Loss for Older Women
WEDNESDAY, June 12, 2024 – Older women with chronic kidney disease might wind up losing so many teeth they aren’t able to chew and talk effectively, a new study warns. Postmenopausal women with k...
Risk for Kidney Complications Increased After Heart Failure Hospitalization
WEDNESDAY, June 5, 2024 – Older adults with heart failure have considerable risk for kidney complications, with 6 percent progressing to dialysis at one year after hospitalization, according to a...
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 – For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from cardiovascular causes,...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 – Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease, according to a study...
Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes
FRIDAY, May 24, 2024 – Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found. The drug significantly reduces the...
Women Face Worse Chronic Kidney Disease Management in Primary Care
MONDAY, May 20, 2024 – Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter published online May 16 in the Journal of the American...
Vitamin D Deficiency Tied to Worse Outcomes With Early Kidney Disease
FRIDAY, May 17, 2024 – Vitamin D deficiency is associated with increased risks for cardiovascular mortality and chronic kidney disease (CKD) progression in patients with early-stage disease,...
Negative Link Seen for Oxidative Balance Score With Chronic Kidney Disease
FRIDAY, May 17, 2024 – There is a negative association for oxidative balance score (OBS) with chronic kidney disease, according to a study published online April 23 in Frontiers in Nutrition. Yuyu...
Men Face More Diabetes Complications Than Women
FRIDAY, May 17, 2024 – Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published online May 16 in the Journal of ...
SGLT2 Inhibitors Improve Outcomes in Patients With Diabetes Plus Kidney Disease
THURSDAY, May 2, 2024 – Use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) is associated with a substantially lower risk for dialysis and cardiovascular disease in patients with type 2 d...
US FDA Approves Jardiance for the Treatment of Adults with Chronic Kidney Disease
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to reduce the risk of sustained ...
FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
WHIPPANY, N.J.-- July 9, 2021 (BUSINESS WIRE)-- Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved Kerendia (finerenone), a first-in-class nonsteroidal...
Farxiga Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression With and Without Type-2 Diabetes
30 April 2021 Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction...